PRKAA2 and metabolic dysfunction-associated steatohepatitis: Let-7a-5p, let-7c-5p, miR-15b-5p, miR-26a-5p, miR-423-5p, inhibit the AMPK complex, disturbing the energy balance in the liver, contributing to the formation of NASH.